Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 8, 2002, Pages 2666-2676

  Baptiste, Darryl C ^a   Hartwick, Andrew T E ^a   Jollimore, Christine A B ^a   Baldridge, William H ^a   Chauhan, Balwantray C ^a   Tremblay, Fraņois ^a   Kelly, Melanie E M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BRIMONIDINE; CALCIUM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; METOPROLOL; N METHYL DEXTRO ASPARTIC ACID; TIMOLOL; YOHIMBINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL CULTURE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLIA; IMMUNOCYTOCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA; RETINA CELL; RETINA GANGLION CELL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BETAXOLOL; CALCIUM; CELL CULTURE TECHNIQUES; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FURA-2; GLUTAMIC ACID; METOPROLOL; N-METHYLASPARTATE; NEUROGLIA; NEUROPROTECTIVE AGENTS; QUINOXALINES; RATS; RATS, LONG-EVANS; RETINA; RETINAL GANGLION CELLS; TIMOLOL;

EID: 0036322780     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Neuronal death in glaucoma
2. Retinal ganglion cell death in glaucoma: The how, the why, and the maybe
3. The optic nerve
4. Programmed cell death of retinal ganglion cells during experimental glaucoma
5. Apoptosis in adult retinal ganglion cells after axotomy
6. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis
7. Apoptosis in ocular disease: A molecular overview
8. TUNEL-positive ganglion cells in human primary open-angle glaucoma
9. What happens to the optic disc and retina in glaucoma?
10. Physiology and pathophysiology of nitric oxide in the retina
11. Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death
12. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture
13. The potential of neuroprotection in glaucoma treatment
14. Neuroprotection in relation to retinal ischemia and relevance to glaucoma
15. Apoptosis, excitotoxicity, and neuropathology
16. Calcium and neuronal death
17. Is neuroprotection a viable therapy for glaucoma?
18. Protection of rabbit retina from ischemic injury by flupirtine
19. Apparent independent action of nimodipine and glutamate antagonists to protect cultured neurons against glutamate-induced damage
20. Calcium channel antagonists in the prevention of neurotoxicity
21. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro
22. Apoptosis and caspases after ischemiareperfusion injury in rat retina
23. Medical treatment of glaucoma and the promising perspectives
24. Clinical experience with brimonidine tartrate, an α2-agonist
25. Medications used in chronic glaucoma therapy: Adrenergic agents: Blockers and agonists
26. Ocular betaxotol: A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension
27. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma
28. Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage
29. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration
30. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina
31. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure
32. Alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia
33. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death
34. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
35. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA
36. Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors
37. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension
38. RGC death in mice after optic nerve crush injury: Oxidative stress and neuroprotection
39. Mammalian retinal pigment epithelial cells in vitro respond to the neurokines ciliary neurotrophic factor and leukemia inhibitory factor
40. Optical recordings of the effects of cholinergic ligands on neurons in the ganglion cell layer of mammalian retina
41. In vitro retina as an experimental model of the central nervous system
42. Glutamate receptors on ganglion cells in the rabbit retina: Evidence for glutamate as a bipolar cell transmitter
43. Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects
44. Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells
45. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex
46. Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltagedependent calcium channels in guinea-pig artery and vein
47. The Ca2+ channel blocking action of the βblockers in bovine retinal microartery
48. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery
49. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: Potential neuroprotective effects of beta-blockers
50. Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: Comparison with other beta-adrenoceptor antagonists
51. From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury
52. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina
53. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor
54. Effects of basic fibroblast growth factor in retinal ischemia
55. Alpha2-adrenergic agonists selectively activate extracellular signal- regulated kinases in Muller cells in vivo
56. Presynaptic alpha2adrenoceptors inhibit excitatory synaptic transmission in rat brain stem
57. 2-adrenergic receptor subtypes in human ocular tissue homogenates
58. Molecular and pharmacological identity of the alpha 2D-adrenergic receptor subtype in bovine retina and its photoreceptors
59. Inhibition of N-type calcium channels: The only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release
60. Activation of alpha 2-adrenoceptors causes inhibition of calcium channels but does not modulate inwardlyrectifying K+ channels in caudal raphe neurons
61. Effect of G protein heterotrimer composition on coupling of neurotransmitter receptors to N-type Ca(2+) channel modulation in sympathetic neurons
62. Retinal ganglion neurons express a toxinresistant developmentally regulated novel type of high-voltage-activated calcium channel
63. Calcium channels in solitary retinal ganglion cells from post-natal rat
64. Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels
65. Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension
66. Distribution of betaxolol to posterior ocular tissues of the Cynomolgus monkey following a 30-day BID topical ocular regimen of betopic S
67. Timolol concentrations in rat ocular tissues and plasma following topical and intraperitoneal dosing